NCT05155085 - A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis | Biotech Hunter

Enrollment

131

Participants

Timeline

Start Date

June 27, 2022

Primary Completion Date

December 18, 2023

Study Completion Date

April 17, 2024

Conditions

Atopic Dermatitis

Interventions

DRUG

AK002

Lirentelimab (AK002) is a humanized non-fucosylated immunoglobulin G1(IgG1)monoclonal antibody directed against Siglec-8

OTHER

Placebo

Trial Locations (55)

11021

Allakos Investigational Site 218-029, Great Neck

12203

Allakos Investigational Site 218-201, Berlin

14620

Allakos Investigational Site 218-053, Rochester

19055

Allakos Investigational Site 218-209, Schwerin

19103

Allakos Investigational Site 218-010, Philadelphia

20037

Allakos Investigational Site 218-045, Washington D.C.

21162

Allakos Investigational Site 218-069, White Marsh

21204

Allakos Investigational Site 218-012, Towson

33134

Allakos Investigational Site 218-008, Miami

33172

Allakos Investigational Site 218-018, Doral

33467

Allakos Investigational Site 218-046, Greenacres City

33607

Allakos Investigational Site 218-020, Tampa

33614

Allakos Investigational Site 218-007, Tampa

34239

Allakos Investigational Site 218-048, Sarasota

35058

Allakos Investigational Site 218-074, Cullman

35209

Allakos Investigational Site 218-034, Birmingham

39104

Allakos Investigational Site 218-210, Magdeburg

40509

Allakos Investigational Site 218-068, Lexington

45236

Allakos Investigational Site 218-001, Cincinnati

45324

Allakos Investigational Site 218-062, Fairborn

45657

Allakos Investigational Site 218-202, Recklinghausen

49074

Allakos Investigational Site 218-205, Osnabrück

49393

Allakos Investigational Site 218-203, Löhne

55128

Allakos Investigational Site 218-204, Mainz

55131

Allakos Investigational Site 218-213, Mainz

56529

Allakos Investigational Site 218-058, Dilworth

59808

Allakos Investigational Site 218-063, Missoula

60590

Allakos Investigational Site 218-212, Frankfurt am Main

64283

Allakos Investigational Site 218-215, Darmstadt

Allakos Investigational Site 218-216, Darmstadt

68144

Allakos Investigational Site 218-032, Omaha

70526

Allakos Investigational Site 218-055, Crowley

73118

Allakos Investigational Site 218-003, Oklahoma City

73120

Allakos Investigational Site 218-015, Oklahoma City

75230

Allakos Investigational Site 218-052, Dallas

78758

Allakos Investigational Site 218-049, Jacksonville

80923

Allakos Investigational Site 218-071, Colorado Springs

81369

Allakos Investigational Site 218-218, Munich

84107

Allakos Investigational Site 218-047, Murray

85018

Allakos Investigational Site 218-025, Gilbert

85258

Allakos Investigational Site 218-041, Scottsdale

89030

Allakos Investigational Site 218-026, Las Vegas

89119

Allakos Investigational Site 218-050, Las Vegas

90057

Allakos Investigational Site 218-056, Los Angeles

90404

Allakos Investigational Site 218-013, Santa Monica

Allakos Investigational Site 218-033, Santa Monica

91054

Allakos Investigational Site 218-207, Erlangen

91303

Allakos Investigational Site 218-072, Canoga Park

92123

Allakos Investigational Site 218-073, San Diego

94132

Allakos Investigational Site 218-051, San Francisco

97210

Allakos Investigational Site 218-061, Portland

98115

Allakos Investigational Site 218-009, Seattle

02111

Allakos Investigational Site 218-066, Boston

01069

Allakos Investigational Site 218-208, Dresden

07548

Allakos Investigational Site 218-211, Gera